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Summary: Serum lipoproteins were stained by the addition of
Sudan Black B solution. The normal lipoproteins and the
excess of Sudan Black were removed with heparin and zinc
acetate solution. The abnormal lipoprotein-X remained in
the supernatant, the blue colour of which was measured. The
empirically obtained constant was used for calculation, thus
avoiding standardization.
Färb Stoffbindungsmethode zur schnellen kalorimetrischen
Bestimmung des für Cholestase charakteristischen Lipoprotein-X
Zusammenfassung: Die Serumlipoproteine wurden durch Zugabe
von Sudanschwarz-B-Lösung gefärbt. Die normalen Lipoproteine
und der Überschuß an Sudanschwarz wurden mittels Heparin
und Zinkacetatlösung ausgefällt. Das abnormale Lipoprotein-X
blieb in dem blaugefärbten Überstand, dessen Farbe gemessen
wird. Die empirisch ermittelte Konstante würde zur Berechnung
benutzt, wodurch die Standardisierung überflüssig ist.
Introduction
The properties and significance of lipoprotein-X were mentioned
in the previous paper (1). The value of its quantitative determina-
tion, e.g. for assessing the degree of cholestasis and possibly for
differentiating between the extra- and intrahepatic types was
discussed in Narayanan's review (2). In the present communica-
tion the same principle for removing the lipoproteins other than
lipoprotein-X was used äs previously (1). Sudan Black B was
utilized to stain serum lipoproteins of which only the blue-
stained lipoprotein-X remained in solution after heparin^Zn2'1"
precipitation. Other lipoproteins, together with the excess of
Sudan Black, were removed wjth the precipitate.
Materials and Methods
Reagents
1. A saturated solution of Sudan Black B (£. Merck, Darmstadt,
FRG) in ethylene glycol was prepared by gentle mechanical
mixing of 0.5 g of the dye with 100 ml of the solvent for 0.5 h.
After aboüt l week Standing (with occasional mixing) in the
dark at room temperature the Suspension was centrifuged at
about 3000 g for 20 min. The supernatant representing a stock
solution of Sudan Black was decanted off. To 10 ml of ethanol
50 ! of this Sudan Black solution were added (the tip of the
Eppendorf pipette was rinsed out into this volume of ethanol).
This ethanolic solution should give an absorbance of 0.35-0.36
at 610 nm (glass cuvette, l cm path). If this is not the case, the
Sudan Black stock solution should be diluted with ethylene
glycol until the ihdicated absorbance is attained (after the
dilution with ethanol). Usually this working solution of Sudan
Black in ethylene glycol ist stable for several weeks in the dark
at room temperature. Later, when its colour decreases, the more
concentrated stock solution should be added to reach the in-
dicated absorbance.
2. Heparin (l g) and 0.15 mol of NaCl per l of water.
3. Zinc acetate 0.26 moi/1 of water.
4. Normal human serum preserved with NaNa (30 mmol/1) for
the dilution of serum samples with high lipoprotein-X levels; this
can be stored for 2 weeks at about 4 9C (not frozen).
Procedure
Each patient's serum was examined in 2 settings in order to
avoid the need to repeat the test in the case of high lippprotein-X
levels:
1. 150 of the tested serum,
2. 25 \ of the tested serum diluted with 125 ! of normal serum.
To each of the 2 test tubes 200 of the working solution of
Sudan Black in ethylene glycol were added, mixed well, and after
about 5 min (or later) 250 of heparin-NaQ were added. The
Contents were mixed and 50 of the zinc acetate solution were
added. After thorough mixing the tubes were placed in a water
bath at 40 °C for l h, then in a bath of 25 °C for 5 min. The
tubes were centrifuged for 20 min at about 3000 g. To 300
of the supernatant 300 of water were added and the blue
colour (in the case of positive sera) was measured at 610 nm
in a Sarstedt plastic cuvette (Nümbrecht-Rommelsdorf, FRG),
light path l cm, width 0.4 cm against water blank (Spekol 10,
C. Zeiss, Jena, GDR). The colour was stable for several hours.
Only when the absorbance of the undiluted sample exceeded
l .00 was the absorbance of the diluted sample taken in account
(after its multiplication by 6).
The absorbance was converted to g/l lipoprotein-X by multi-
plication by the constant 1.92 (± 0.047, S.D.). This constant was
obtained from 9 calibration curves (with a total of 54 Standards)
using the concentrated lipoprotein-X Standard solution (3)
diluted serially with normal serum (fig. 1).
The calibration curve was linear up to the lipoprotein-X con-
centration of 2.0 g/l. When higher concentrations occur in
serum the sample must bc diluted with normal serum (and the
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Fig. 1. Calibration curve.
Absorbance values at 610 nm. The lipoprotein-X solution
of a known concentration (3) was added in increasing
amounts to normal pooled serum to give lipoprotein-X
levels indicated on the abscissa. Each absorbance value
(empty circles) is the arithmetic mean of 9 analyses. The
vertical bars indicate ± S.D. (The absorbance values per-
taining to the 2.5 g/l level were not included in the calcu-
lation from which the constant 1.92 was derived.)
analysis repeated). The given constant holds pnly for the Sudan
Black working solution of the colour density r nge indicated
above. Lower Sudan Black concentrations gave lower absorb-
ances for the same lipoprotein-X level. Thus, e.g., at an absorb-
ance of 0.31 for the diluted Sudan Black, l g/l lipoprotein-X
gave an absorbance of only 0.49, whereas 0.52 was obtained
with the correct concentration of the (Sudan Black working
solution (absorbance of 0.35-0.36 when diluted with ethanol).
Results and Discussion
Sera from normal persons and sera from various disease states
were investigated by the described method and the results were
compared with the enzymatic method (1) and with agar gel
electrophoresis (4) (tab. 1).
Both the enzymatic (1) and the present method correlated well
(for 28 positive sera: r = 0.9997, enzymatic rhean χ = 4.14 g/l,
present method mean y - 4.01 g/l, y = 0.971 χ-0.03).
One of the serum samples was analyzed 10 times in one run
giving 1.25 ± 0.01 g/l (CV = 0.80%) and (preserved with NaN?
at 4 °C) on 10 c nsecutive days with the result of 1.24 ± 0.016
g/l (CV= 1.29%).
To 4 sera (0.16, 0.33, 0.58, 0.99 g/l) lipoprotein-X was added
(1.50,1.0, 0.98,0.50 g/l) which caused an increase of the leveis
(to: 1.54,1.38,1.67,1.5 2 g/l, resp.)thus giving recoveriespf
101 ± 6.8% (S.D.).
Tab. 1. Replicate (n) lipoprotein-X analyses by the Sudan Black colorimetric method, by the enzymatic method (1) and by agar
electrophoresis.
Diagnosis Patient Lipoprotein-X (g/l)
Sudan Black procedure
n Mean ± S.D.
Enzymatic Agar elec-
CV (%) procedure trophoresis
Control healthy
Plasmocytoma
Carcinoma coli
Cholecystolithiasis
Hepatitis chronica
Cholecystolithiasis
Decompensatio cordis
Cholecystolithiasis
Status post cholecystectomy (1 d)
Schizophren., cholestasis intrahep. p.
chloropromazine
Cholecystitis, choledocholith. susp.
Colica biliaris susp.
Colica biliaris
Colica biliaris recidiv.
Cholecystolithiasis
Choledocholithiasis
Choledo cholithiasis
Choledocholithiasis
Choledochoiithiasis
Choledocholithiasis
Choledocholithiasis
Choledocholithiasis
Choledocholithiasis
Choledocholithiasis (2 d after surgery)
Choledocholithiasis (2 d after surgery)
Choledocholithiasis (1 week after surgery)
Choledocholithiasis (1 d after surgery)
Atresia viarum biliafum
Carcinoma pancreatis
Tumor reg. perihepat.
Tumor capitis pancreat.
Tumor reg. infrahep.
Tumor viarum biliarum
Tumor capitis pancreat.
H.V.d
T.0.9
V.A.d
O.B.9
H.E.<5
B.F.d
P.O. 9
N.H.9
D.K.d
A.A.d
S.V.d
N.M.9
P.M. 9
P.R.d
H.A.d
E.D.9
K.0.9
S.R.9
M.I.d
F. A. 9
Ne.M.9
F.E. 9
K.R.d
S.P.d
KJ.d
J.R.9
K.L.d
M.K.9
S.K.9
M.A.d
H. A. 9
Ho.M.9
PJ.d
1
4
1
2
4
1
4
5
4
4
4
4
4
4
3
5
4
4
4
4
4
4
4
4
4
4
4
4
4
4
8
4
4
4
not detectable
not detectable
not detectable
riot detectable
not detectable
not detectable
0.05 ±0.002 .
0.04 ± 0.002
0.03 ± 0.001
0.24 ± 0.008
1.16 ±0.011
0.08 ± 0.003
0.26 ± 0.009
0.51 ±0.010
0.15 ± 0.006
0.21 ± 0.009
4.86 ± 0.078
14.85 ± 0.101
2.62 ±0.01 8
2.91 ± 0.014
1.13 ±0.005
1.12 ±0.020
6.68 ±0.102
3.42 ± 0.034
3.24 ±0.058
0.1 2 ±0.003
0.46 ± 0.010
10.56 ± 0.000
5.94 ± 0.039
24.14 ±0.171
1.62 ±0.028
18.78 ±0.160
0.41 ± 0.004
„6.76 ±0.102
4.00
5.00
4.70
3.33
0.95
3.75
3.46
1.96
4. 00
4.30
1.60
0.68
0.69
0.48
0.44
1.79
1.53
1.00
1.79
2.50
2.Ϊ7
0
0.66
0.71
1.73
0.85
0.98
1.51
n.d.
n.d.
n*d.
n.d.
n.d.
• n.d.
0.06
0.07
0.04
0.26
1.26
0.09
0.27
0.51
0.24
0.31
4.97
15.15
2.86
3.00-
1.27
1.23
6.88
3.34
3.41
0.13
0.48
10.76
5.52
24.86
1,84
19.75
0.48
6.81
0
0
0
0
0
0
0
0
0
±
+
±
±
±
±
±
±
±
» i
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Bilirubin and drugs did not interfere. The limitations, i.e. ex-
cessive hyperlipaemia, were discussed in the previous communi-
cation (1).
This method is the m o st simple and rapid one of the hitherto
described procedures for lipoprotein-X determination. Possibly,
it is easier to perform than the conventional qualitative electro-
phoretic test. It makes it possible to estimate lipoprotein-X
even at very low serum levels with reasonable accuracy and with
the use of the simplest materials.
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